News | Cardiac Imaging | March 30, 2016

Toshiba Showcases Diagnostic Imaging at ACC 2016

Company will demonstrate new advances in CT, MR, angiography and ultrasound

Toshiba, ACC 2016, American College of Cardiology, CT, MR, ultrasound, angiography, interventional radiology

Infinix 4-D CT image courtesy of Toshiba America Medical Systems.

March 30, 2016 — Toshiba America Medical Systems Inc. announced it would demonstrate the following diagnostic imaging technologies at this year’s American College of Cardiology 2016 Annual Scientific Session, April 2-4 in Chicago:

Computed Tomography

Toshiba will showcase the ability of its Aquilion One family of computed tomography (CT) systems to help physicians accurately plan transcatheter aortic valve implantation/repair (TAVI/TAVR) procedures. The Aquilion One family features whole-heart volumetric 0.275-second rotation and Variable Helical Pitch (vHP), which automatically changes from an electrocardiogram (ECG)-gated to a non-ECG-gated acquisition during a single helical scan; this reduces IV contrast and radiation dose. Vital’s CT TAVR planning application can also be utilized during the planning process to visualize and accurately plan valve placement.


The new Infinix 4-D CT seamlessly integrates interventional radiology (IR) and CT into one solution, enabling clinicians to provide faster, safer and more accurate interventions. The system allows clinicians to plan, treat and verify in a single clinical setting to avoid transferring patients between departments, which decreases both procedure time and risk of infection. These features also minimize time spent away from patients, allowing clinicians to focus on providing quality care. Infinix 4-D CT One Vision is the only combined angiography-CT system that offers 16 cm of CT coverage in one fast rotation, according to the company. True CT instead of CT-like images on demand during procedures, such as valve replacements, can assist clinicians in better visualization, improved device manipulation and verification of results. The Infinix 4-D CT One Vision enables dynamic and functional imaging including whole-organ volumetric CT perfusion.

Available on the entire Infinix product line of cardiovascular X-ray systems, Toshiba’s Dose Tracking System (DTS) makes it possible to measure estimated peak radiation skin dose during interventional procedures, allowing clinicians to provide safer exams and a better patient experience. Expanded bi-plane (frontal and lateral) coverage, and the ability to track cradle movement, allows the technology to monitor dose in a wider range of applications, such as neurovascular procedures.

On the CT side, Adaptive Iterative Dose Reduction 3-D (AIDR 3-D), has been automated and optimized to reconstruct images with speeds that allow the algorithm to be used for any clinical situation, including 3-D Volumetric Fluoroscopy mode, helping to lower radiation dose and maximize image quality all with accelerated workflow.


At this year’s ACC annual meeting, Toshiba will showcase its Vantage Titan 3T magnetic resonance (MR) system’s ability for clinicians of all skill levels to obtain accurate and reproducible cardiac images easier and faster. To improve workflow, exam times and offer higher reproducibility, the system features several automatic alignment tools, including SUREVOI Cardiac and CardioLine. The SUREVOI Cardiac alignment tool automatically detects appropriate settings for cardiac examinations by recognizing the position of the heart and aligns the patient. CardioLine then automatically detects anatomical landmarks to determine the angle of the heart to complete alignment of six standard cardiac views without any operator interaction.


Toshiba’s Aplio 500 Platinum CV ultrasound system delivers premium image quality, advanced visualization capabilities and workflow automation tools in an easy-to-use system. The system features robust 2-D Wall Motion Tracking technology, which provides quantitative analysis of myocardial wall motion with confidence and reproducibility. Using Speckle-tracking based quantification measurements in all directions (radial, circumferential and longitudinal), the Aplio 500 Platinum CV is designed to provide comprehensive information at the patient’s bedside.

Toshiba also offers customers a cost-effective solution to improve pediatric patient care with a new pediatric and neonatal transducer on its Xario 200 ultrasound system. For the first time, the new 70BT transducer on the Xario 200 allows physicians to produce high-quality images in a wide range of pediatric and neonatal patient applications. Providing a compact, lightweight footprint, the Xario 200 makes it easier to fit into tight spaces, such as the intensive care unit (ICU) and neonatal intensive care unit (NICU), and maneuver easily from room to room.

For more information:

Related Content

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-
ACC Cancels 2020 Conference Amid Coronavirus Concerns. #COVID19 #coronavirus #2019nCoV
Feature | ACC | March 09, 2020 | Dave Fornell, Editor
March 9, 2020 — Less than week after the American College of Cardiolog...
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors


News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a